We're here for you if you want to talk

0808 2080 888

[email protected]

News and blogs

326 results found.

Ambitious £4 million project to develop clinical platform for blood cancer prevention

World Cancer Day sees Blood Cancer UK and The Leukemia & Lymphoma Society announce the start of a transformative five-year, £4 million research project in Cambridge. The work will establish a clinical platform to identify individuals at high risk of certain blood cancers and develop interventions to prevent people from progressing to these diseases.

4th Feb 2024

Man in red lab coat working with a women and man in white lab coats

Non-Hodgkin lymphoma drug, Tepkinly, authorised for use on NHS

Tepkinly (epcoritamab), a treatment for the blood cancer, diffuse large B-cell lymphoma is to be made available on the NHS as a third line treatment.

1st Feb 2024

From despair to hope: The Matthew Wilson Multiple Myeloma Fund

Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.

26th Jan 2024

Matthew Wilson, a member of the Board, smiling against a plan white background.

Our response to the Government's plan for UK commercial clinical trials

Refreshing clinical trials activity must benefit people with blood cancer across the UK.

18th Jan 2024

Photo by R Spegel on Unsplash

Cards for when "get well soon" doesn't quite cut it

We're thrilled to announced our partnership with artist Vicky Yorke, whose unique card designs and messages draw from her own experience of chronic myeloid leukaemia (CML) – with every purchase supporting life-saving blood cancer research.

12th Jan 2024

Vicky Yorke empathy cards

Insurance leader Matthew Wilson to be next chair of trustees of Blood Cancer UK

Blood Cancer UK will appoint insurance leader, and advisor to Fairfax Financial and Lloyd’s of London, Matthew Wilson as its next chair of trustees. Matthew, who has been appointed after a robust, independent recruitment process, will formally start his role in early 2024, as current chair John Ormerod’s term comes to an end after 5 years in post.

1st Dec 2023

Man smiling in a suit

Amwins Global Risks partners with Blood Cancer UK to raise funds for myeloma

Blood Cancer UK has become Amwins Global Risks’ charity partner, with the partnership expected to raise around £100,000 in the next two years. The partnership will also raise the awareness of blood cancer, which is the third biggest cancer killer in the UK.

20th Nov 2023

Stay updated with our organisational strategy

The latest news on our organisational strategy.

10th Nov 2023

Portrait of Helen Rowntree

Research links childhood CT scan exposure to increased blood cancer risk

In new research, scientists have linked increased CT scan exposure to an increased risk of blood cancer in younger people.

9th Nov 2023

How our research gave vaccine answers to people with blood cancer

As our QResearch project formally comes to a close, we look at how scientists were able to understand the effectiveness of the COVID-19 vaccine for clinically extremely vulnerable people during the pandemic.

2nd Nov 2023

An image of covid vaccine vials

The stolen legacy of Henrietta Lacks

Taken without her consent, Henrietta's 'immortal' cells have had an everlasting contribution to research – while raising important issues around medical ethics and patients' rights. Henrietta's death was the start of a long battle for justice, but 70 years later, Henrietta's family finally received closure.

24th Oct 2023

Henrietta Lacks

Non-Hodgkin lymphoma drug authorised for use in the UK

A drug for non-Hodgkin lymphoma, epcoritamab, has been authorised for use in the UK for adults.

24th Oct 2023

This MDS World Awareness Day, four people share their story

October 25 every year is World MDS Awareness Day. This year, four people share their story of living with MDS.

23rd Oct 2023

Ally and his young daughter. Ally is wearing fire brigade uniform

Drug, zanubrutinib, now recommended for adults with CLL across the UK

Zanubrutinib has been recommended for adults with the blood cancer, chronic lymphocytic leukaemia (CLL) in England.

19th Oct 2023

People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.

People with the blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to benefit from a new treatment – glofitamab – on the NHS.

18th Oct 2023

We're calling for UK wide guidance for healthcare staff on masks and testing

As we head into winter, and COVID rates rising, we want to help protect those with blood cancer. We’re calling for UK-wide guidance to be reintroduced asking healthcare staff, to wear masks in clinical settings.

16th Oct 2023

A healthcare professional and patient looking at each other. The patient is sitting in a chair having treatment administered.

What we can achieve with £1 million

We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers

4th Oct 2023

A collage of images of our 5 new researchers working in the lab

The story of Dr Jane C Wright, pioneer of blood cancer research

Born in 1919, Dr Wright transformed chemotherapy from an untested, experimental last resort, to a proven, effective blood cancer treatment. Throughout her career Jane overcame prejudice and other barriers to leave a legacy of millions of lives saved.

28th Sep 2023

A scientist  - Jane C Wright, surgeon and early chemo researcher, poses next to a microscope in a black and white photograph.

"Father of the blood bank" - Charles R. Drew's story

For Black History Month, we are celebrating Charles R. Drew who was an African American surgeon and researcher who pioneered in the field of blood transfusions, blood storage and created the first blood banks.

28th Sep 2023

Charles R Drew Portrait By Associated Photographic Services

Charity welcomes Liberal Democrats leader’s cancer pledge after he revealed insight into blood cancer experience

Blood Cancer UK have welcomed the Lib Dem leaders cancer pledge after he revealed insight into blood cancer experience.

26th Sep 2023